Analyst Ratings for Cara Therapeutics (CARA) [Sells]

CARA Rating Summary

CARA Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CARA
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $24.60 (+84.8%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like CARA Ratings? Also take a look at SWKH, MTSC, APH, CRIS

CARA Ratings News